European drug security regulators are at the moment investigating the favored weight-loss drug Ozempic as a result of experiences from sufferers suggesting a possible hyperlink to suicidal ideas and self-harm. The European Medicines Agency (EMA) has revealed {that a} security committee is analyzing weight-loss drugs produced by Novo Nordisk, together with Ozempic, Saxenda, and Wegovy, after three circumstances of sufferers experiencing suicidal ideas had been reported to Iceland’s well being regulator.
According to the Icelandic Medicines Agency, two customers of Ozempic and one person of Saxenda reported having suicidal ideas, whereas one other Saxenda person reported ideas of self-injury. Ozempic, promoted as a once-a-week injection for the remedy of Type 2 diabetes and heart problems, has gained vital recognition just lately as a result of its exceptional weight-loss results.
The Post has reached out to Novo Nordisk for remark relating to this matter.
Although varied uncommon negative effects have been linked to Ozempic, resembling “Ozempic butt” the place customers declare their buttocks and stomachs have flattened, the newest alleged aspect impact is of higher concern. Saxenda, an earlier weight-loss shot from Novo Nordisk, reportedly much less efficient than Ozempic, was developed as a persistent weight administration product, together with the obesity-management drug Wegovy.
While no circumstances of damaging emotions had been reported by Wegovy sufferers, the EMA, liable for monitoring the security of medicines used within the EU, has initiated an investigation into all of Novo Nordisk’s weight-loss remedies, in addition to different drugs containing semaglutide or liraglutide. Both Ozempic and Wegovy are semaglutide injections.
Although Novo Nordisk doesn’t warn Ozempic customers about potential psychological well being negative effects, the Mayo Clinic clearly states that semaglutide could “cause some people to have suicidal thoughts and tendencies or become more depressed.”
However, Novo Nordisk does present psychological health-related warnings for Wegovy, acknowledging that it might trigger “suicidal behavior and ideation.” The firm’s web site advises monitoring sufferers taking Wegovy for despair, suicidal ideas or habits, and any uncommon modifications in temper or habits.
Saxenda, then again, is a day by day liraglutide injection. Liraglutide and semaglutide belong to the identical class of medicines. These potent medicine mimic the actions of the GLP-1 hormone, which is launched by the pancreas after consuming and helps folks really feel full.
Semaglutide is often most well-liked for weight-loss remedies as a result of its confirmed effectiveness and longer half-life in comparison with liraglutide, which means it stays within the system for an extended period and delays the return of starvation sensations.
Similar to Ozempic, Saxenda was initially used primarily for sustaining blood sugar ranges in people with Type 2 diabetes earlier than it gained recognition as a stylish weight-loss answer. Saxenda’s web site advises towards utilizing the drug for people with a historical past of despair, suicidal ideas, or psychological well being points, and it lists “depression or thoughts of suicide” as a possible aspect impact of the treatment.
Source: www.anews.com.tr
